Feedback PLC (LON:FDBK)

Feedback PLC (LON:FDBK)


Share Price
0.78 p
Change
-0.175 (-18.42 %)
Market Cap
£2.89 m
Proactive Investors - Run By Investors For Investors

Feedback PLC RNS Release

Total Voting Rights


RNS Number : 9620I
Feedback PLC
30 November 2018
 

30 November 2018

Feedback plc

Total Voting Rights

Cambridge, 30 November 2018: Feedback plc (AIM: FDBK, "Feedback" or the "Company") announces that the Company's issued share capital, as at the date of this announcement, comprises 373,283,250 ordinary shares, with one voting right per share ("Ordinary Shares"). The Company does not hold any ordinary shares in treasury. Therefore, the total number of ordinary shares and voting rights in the Company is 373,283,250.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

 

Feedback plc

Alastair Riddell, Executive Chairman

Lindsay Melvin, CFO 

 

+44 (0)1954 718072

[email protected]

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai 

 

+44 (0)20 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey 

 

+44 (0)20 7469 0936

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

 

Instinctif Partners

Rozi Morris/ Deborah Bell/ Phillip Marriage

+44 20 3815 8880

 

 

+44 (0)20 7457 2020

[email protected]

 

Notes to editors

About Feedback plc

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS). For more information, see www.fbk.com

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TVRUKVVRWVAAUAA

Feedback PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use